What Has Michael J. Fox Done for Parkinson's Research? Inside the Mission Behind His Emotional Emmys Honour

Michael J. Fox received a huge ovation at the 2026 Emmys as the 65-year-old actor accepted the Bob Hope Humanitarian Award for his contributions to Parkinson's research and advocacy.

Diagnosed at just 29, the Back to the Future and Family Ties star initially kept his condition secret over fears it could hurt his career. After going public in 1998, Fox turned his diagnosis into a mission that has since directed billions of dollars towards Parkinson's research.

Michael J. Fox Foundation Has Funded $3 Billion in Research

Fox founded the Michael J. Fox Foundation for Parkinson's Research in 2000 to accelerate better treatments and ultimately find a cure.

The organisation has become the world's largest nonprofit funder of Parkinson's research and has funded $3 billion (£2.2 billion) in research to date, according to the Television Academy.

Rather than conducting research himself, Fox has used his profile to attract funding and bring together scientists, patients, pharmaceutical companies, donors and clinical trial participants.

In his Emmys speech, Fox said he had vowed to fund 'the best science in the world'. He credited researchers, donors, staff and patients for the foundation's progress.

How Fox Has Changed Parkinson's Research

The foundation's work stretches across the Parkinson's research pipeline, from investigating the biology behind the disease to developing potential treatments and improving care.

In February and March 2026 alone, it awarded more than $195 million (£144 million) to 84 projects, including studies of potential treatment targets and efforts to develop better tools to diagnose and track Parkinson's.

The foundation also provides researchers with datasets and biological samples while supporting efforts to recruit patients for clinical trials.

One of its most significant projects is the Parkinson's Progression Markers Initiative, or PPMI, a long-term study designed to improve understanding of how Parkinson's begins and progresses.

Parkinson's Biomarker Research Marks Major Advance

Research supported through PPMI has contributed to advances involving alpha-synuclein, a protein closely associated with Parkinson's.

Scientists have developed alpha-synuclein seed amplification assays that can detect abnormal forms of the protein in cerebrospinal fluid, giving researchers a biological way to identify Parkinson's-related disease processes.

The foundation is also supporting research into less invasive approaches, including efforts to develop a blood-based test that could produce results comparable with the existing cerebrospinal fluid assay. The research could eventually help identify patients earlier and improve recruitment for clinical trials.

Fox Turned His Diagnosis Into Parkinson's Advocacy

Fox told the Emmys audience that accepting Parkinson's did not mean he had to 'surrender' to it.

His decision to disclose his diagnosis helped challenge perceptions that Parkinson's affects only older people. The Lasker Foundation, which gave Fox its 2026 Public Service Award, credited his advocacy with raising awareness, reducing stigma and putting patients more directly at the centre of Parkinson's research.

The Bob Hope Humanitarian Award recognises television figures whose philanthropic efforts have had a lasting impact on society. Previous recipients include Oprah Winfrey, George Clooney, Sean Penn, Ted Danson and Mary Steenburgen.

Fox, who also received his 19th Emmy nomination this year for Shrinking, told the audience he was 'proud of the progress we've made' to benefit Parkinson's patients and their families.